BREAKING
Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 4 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 6 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 10 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 4 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 6 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 10 hours ago
ADVERTISEMENT
Market News

Perrigo Company (PRGO): Q3 2019 Earnings Snapshot

— Perrigo Company plc (NYSE: PRGO) reported Q3 2019 earnings of $1.04 per share, vs. $0.93 expected. — Sales grew 5.1% to $1.2 billion, vs. $1.2 billion expected. — Worldwide Consumer net sales increased 3.3% to $961 million. — Prescription Pharmaceuticals sales improved 13.6% to $230 million. — FY19 GAAP EPS is expected to be […]

$PRGO November 6, 2019 1 min read

— Perrigo Company plc (NYSE: PRGO) reported Q3 2019 earnings of $1.04 per share, vs. $0.93 expected.

— Sales grew 5.1% to $1.2 billion, vs. $1.2 billion expected.

— Worldwide Consumer net sales increased 3.3% to $961 million.

— Prescription Pharmaceuticals sales improved 13.6% to $230 million.

— FY19 GAAP EPS is expected to be $2.01-2.21.  

ADVERTISEMENT

— FY19 adjusted EPS is expected to be $3.85-4.05.

— PRGO shares gained 0.98% following the announcement.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

ADVERTISEMENT